Apex multiple drug concentration semi-quantitative correction solution - Taiwan Registration fa474d37020bf21a859852b72e5913c3
Access comprehensive regulatory information for Apex multiple drug concentration semi-quantitative correction solution in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number fa474d37020bf21a859852b72e5913c3 and manufactured by MICROGENICS CORPORATION. The authorized representative in Taiwan is ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Product Details
This product is used to correct the Apex diazo base salt serum test set and the Apex tricyclic antidepressant test set on the Alinity c analyzer.
A Clinical chemistry and clinical toxicology
A.3200 Clinical Toxicology Corrector
Input;; QMS/QSD
Dates and Status
Nov 02, 2020
Nov 02, 2025

